Global HIV Therapeutics Market Value Will Crawl to Almost $15.3 Billion by 2023, Finds New Report
The Human Immunodeficiency Virus (HIV) treatment landscape is expected to experience a paradigm shift towards integrase inhibitor drugs and single-tablet regimens (STRs). The market growth will mainly be driven by the introduction of novel drugs, such as STRs with improved tolerability, a reduced pill burden or increased efficacy, and an increasing number of people living with HIV who are treated with antiretroviral therapy (ART).
View full press release